Biomarker for predicting or monitoring efficacy of c-MET inhibitor

The invention provides a biomarker for predicting and/or monitoring the efficacy of a c-Met inhibitor; a composition for predicting and/or monitoring the efficacy of a c-Met inhibitor, comprising a material detecting the biomarker; a composition for selecting a subject suitable for the application o...

Full description

Saved in:
Bibliographic Details
Main Authors SHIM, SEON HUI, SONG, YUN JEONG, JUNG, SOO YEON, YOO, HYEON-SEOK
Format Patent
LanguageEnglish
Published 08.07.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides a biomarker for predicting and/or monitoring the efficacy of a c-Met inhibitor; a composition for predicting and/or monitoring the efficacy of a c-Met inhibitor, comprising a material detecting the biomarker; a composition for selecting a subject suitable for the application of a c-Met inhibitor, comprising a material detecting the biomarker; a method for predicting and/or monitoring the efficacy of a c-Met inhibitor using the biomarker; a method for selecting a subject suitable for the application of a c-Met inhibitor using the biomarker; and a method for preventing and/or treating cancer comprising administering a c-Met inhibitor to the selected subject.
Bibliography:Application Number: CN201510008065